Headline "Sol"
The Biojam Holding Group, a reference in the national and international pharmaceutical industry, today assumes a leadership position in the Iberian market, where it pioneered the treatment of Acute Lymphoblastic Leukemia.
Carlos Monteiro, CEO, has given us a better understanding of the origin of this project, which is now responsible for distributing the first and only nasal COVID-19 test produced in Portugal.
